Atrys Health, S.A. (BME:ATRY)

Atrys Health Statistics

Total Valuation

Atrys Health has a market cap or net worth of EUR 261.01 million. The enterprise value is 497.57 million.

Market Cap	261.01M
Enterprise Value	497.57M

Important Dates

The next estimated earnings date is Tuesday, December 23, 2025.

Earnings Date	Dec 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Atrys Health has 75.87 million shares outstanding. The number of shares has increased by 0.12% in one year.

Current Share Class	75.87M
Shares Outstanding	75.87M
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.26%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	229.33
PS Ratio	1.15
PB Ratio	1.08
P/TBV Ratio	n/a
P/FCF Ratio	14.66
P/OCF Ratio	11.21
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.57, with an EV/FCF ratio of 27.96.

EV / Earnings	-20.24
EV / Sales	2.20
EV / EBITDA	22.57
EV / EBIT	116.34
EV / FCF	27.96

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.04.

Current Ratio	0.83
Quick Ratio	0.70
Debt / Equity	1.04
Debt / EBITDA	11.36
Debt / FCF	14.07
Interest Coverage	0.19

Financial Efficiency

Return on equity (ROE) is -9.52% and return on invested capital (ROIC) is 0.53%.

Return on Equity (ROE)	-9.52%
Return on Assets (ROA)	0.45%
Return on Invested Capital (ROIC)	0.53%
Return on Capital Employed (ROCE)	0.91%
Revenue Per Employee	112,222
Profits Per Employee	-12,195
Employee Count	2,045
Asset Turnover	0.38
Inventory Turnover	100.32

Taxes

Income Tax	-1.06M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.93% in the last 52 weeks. The beta is 0.64, so Atrys Health's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+3.93%
50-Day Moving Average	2.97
200-Day Moving Average	3.02
Relative Strength Index (RSI)	73.66
Average Volume (20 Days)	130,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Atrys Health had revenue of EUR 226.24 million and -24.59 million in losses. Loss per share was -0.32.

Revenue	226.24M
Gross Profit	56.34M
Operating Income	4.28M
Pretax Income	-25.48M
Net Income	-24.59M
EBITDA	15.96M
EBIT	4.28M
Loss Per Share	-0.32

Balance Sheet

The company has 13.99 million in cash and 250.52 million in debt, giving a net cash position of -236.53 million or -3.12 per share.

Cash & Cash Equivalents	13.99M
Total Debt	250.52M
Net Cash	-236.53M
Net Cash Per Share	-3.12
Equity (Book Value)	241.53M
Book Value Per Share	3.18
Working Capital	-19.31M

Cash Flow

In the last 12 months, operating cash flow was 23.28 million and capital expenditures -5.48 million, giving a free cash flow of 17.80 million.

Operating Cash Flow	23.28M
Capital Expenditures	-5.48M
Free Cash Flow	17.80M
FCF Per Share	0.23

Margins

Gross margin is 24.90%, with operating and profit margins of 1.89% and -10.87%.

Gross Margin	24.90%
Operating Margin	1.89%
Pretax Margin	-11.26%
Profit Margin	-10.87%
EBITDA Margin	7.06%
EBIT Margin	1.89%
FCF Margin	7.87%

Dividends & Yields

Atrys Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.12%
Shareholder Yield	-0.12%
Earnings Yield	-9.42%
FCF Yield	6.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Atrys Health has an Altman Z-Score of 0.58 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.58
Piotroski F-Score	5